The purchase price for the assets is approximately $15.2 million in stock and cash. Alphatec Spine said that it expects this transaction to contribute approximately $15 million in revenue in 2013. Additional details regarding the transaction will be provided if and when the acquisition is closed.
Alphatec Spine to Acquire Some Assets of Phygen FeaturedWritten by Jaimie Oh | September 27, 2012
Alphatec Holdings' board of directors has approved the company's plans to acquire certain assets of Phygen, a spinal implant manufacturer based in Irvine, Calif.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.